biOasis Technologies (OTCMKTS:BIOAF) Shares Up 0.3%

biOasis Technologies Inc (OTCMKTS:BIOAF) shares shot up 0.3% on Wednesday . The stock traded as high as $0.18 and last traded at $0.18, 2,000 shares changed hands during mid-day trading. A decline of 93% from the average session volume of 29,991 shares. The stock had previously closed at $0.18.

The business’s 50 day moving average price is $0.18 and its 200-day moving average price is $0.18. The firm has a market cap of $11.16 million, a price-to-earnings ratio of -3.67 and a beta of -0.36.

About biOasis Technologies (OTCMKTS:BIOAF)

Bioasis Technologies Inc, a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company's lead program is xB3-001, an xB3 peptide vector-trastuzumab fusion. It is developing xB3, a proprietary platform technology for the delivery of therapeutics and imaging agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders in the areas of high unmet medical needs, including brain cancers, and metabolic and neurodegenerative diseases.

Featured Story: If I purchase shares through a brokerage account, am I the holder of record?

Receive News & Ratings for biOasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for biOasis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.